Multiple morphea-like lesions associated with chronic graft-versus-host disease after cord blood transplantation

Acta Dermato-Venereologica

Volumn 89, Issue 1, 2009, Pages 86-87

  Kawakami, Yoshio ^a   Ohtsuka, Mikio ^a   Kikuta, Atsushi ^a   Yamamato, Toshiyuki ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE SODIUM SUCCINATE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PREDNISOLONE; STEROID; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOTRANSPLANTATION; CASE REPORT; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC GRANULOMATOUS DISEASE; CLINICAL EXAMINATION; DISEASE SEVERITY; DRUG TREATMENT FAILURE; ENGRAFTMENT; FEMALE; HISTOPATHOLOGY; HLA MATCHING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LETTER; MALE; MORPHEA; PRESCHOOL CHILD; PRIORITY JOURNAL; SKIN BIOPSY; SKIN MANIFESTATION; TREATMENT DURATION; UMBILICAL CORD BLOOD;

CHILD, PRESCHOOL; CHRONIC DISEASE; CORD BLOOD STEM CELL TRANSPLANTATION; GRAFT VS HOST DISEASE; HUMANS; MALE; SCLERODERMA, LOCALIZED;

EID: 58549087973     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0527     Document Type: Letter

References (11)

1. Atkinson K. Chronic graft-versus-host disease. Bone Marrow Transplant 1990; 5: 69-82.
2. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945-956.
3. Peñas PF, Jones-Caballero M, Aragüés M, Fernández-Herrera J, García-Díez A. The clinical and histologic spectrum of chronic graft-versus-host disease. J Am Acad Dermatol 2006; 55: 729.
4. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217.
5. Van Vloten WA, Scheffer E, Dooren LJ. Localized scleroderma-like lesions after bone marrow transplantation in man. A chronic graft versus host reaction. Br J Dermatol 1977; 96: 337-341.
6. Peñas PF, Jones-Caballero M, Aragüés M, Fernández-Herrera J, Fraga J, García-Díez A. Sclerodermatous graft-vs-host disease: clinical and pathological study of 17 patients. Arch Dermatol 2002; 138: 924-934.
7. White JM, Devereux S, Pagliuca A, Salisbury JR, du Vivier AW, Creamer D. Koebnerizing sclerodermatous graft-versus-host disease caused by donor lymphocyte infusion and interferon-α. Br J Dermatol 2006; 155: 621-623.
8. Takehara K, Moroi Y, Nakabayashi Y, Ishibashi Y. Antinuclear antibodies in localized scleroderma. Arthritis Rheum 1983; 26: 612-616.
9. Sato S, Fujimoto M, Ihn H, Kikuchi K, Takehara K. Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma. J Am Acad Dermatol 1994; 31: 567-571.
10. Hayakawa I, Hasegawa M, Takehara K, Sato S. Anti-DNA topoisomerase IIα autoantibodies in localized scleroderma. Arthritis Rheum 2004; 50: 227-232.
11. Zhang C, Todorov I, Zhang Z, Liu Y, Kandeel F, Forman S, et al. Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations. Blood 2006; 107: 2993-3001.